Jabbour, E., Lussana, F., Sanchez, P. M., Torrent, A., Rifón, J., Agrawal, V., Tormo, M., Cassaday, R. D., Cluzeau, T., Huguet, F., Papayannidis, C., Rivas, J. M. H., Rijneveld, A., Fleming, S., Vucinic, V., Böll, B., Ikezoe, T., Abdul-Hay, M., Savoie, M. L., Schuh, A., Schwartz, S., Chiaretti, S., Yuda, J., Miyazaki, T., González-Campos, J., Brüggemann, M., Zhang, J., Choudhry, J., Guest, E., Kantarjian, H. (2025). Efficacy of single-agent subcutaneous blinatumomab in adults with relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL): Results from a phase 1/2 dose expansion study with extended follow-up. Blood. https://doi.org/10.1182/blood-2025-5117